Reaction

Areflexia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,653 reports · 112 co-occurring drugs

As of the last recalculation, Areflexia appears in 2,653 FAERS reports alongside 112 co-occurring drug terms. The strongest observed disproportionality signal is SALMETEROL XINAFOATE (PRR 47.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Salmeterol Xinafoate	51	47.3	47.6
Bupivacaine	34	28.9	29.0
Bupropion	103	18.8	18.9
Doxepin	24	18.7	18.8
Esomeprazole Magnesium Capsule, Delayed Release	34	18.6	18.7
Esomeprazole Magnesium Delayed Release Capsules	34	18.6	18.7
Esomeprazole Magnesium Dihydrate	34	18.5	18.6
Instalax Polyethylene Glycol 3350	27	17.2	17.3
Doxepin Hydrochloride	27	16.9	17.0
Polyethylene Glycol 400	27	16.9	16.9
Clobazam	41	13.4	13.4
Phenytoin	35	13.3	13.3
Ethyl Alcohol	45	13.2	13.2
Polyethylene Glycol	18	13.1	13.1
Sevoflurane	13	12.3	12.3
Rifampicin	15	11.7	11.7
Propofol	53	11.6	11.6
Isopropyl Alcohol	49	11.6	11.6
Baclofen	120	11.4	11.4
Alcohol	54	11.1	11.1
Bleomycin Sulfate	14	10.7	10.7
Propranolol Hydrochloride	92	10.3	10.3
Cytarabine	77	10.3	10.3
Captopril	12	9.8	9.8
Daspone	12	9.7	9.7
Dapsone Gel, 5%	12	9.7	9.7
Midazolam	30	9.4	9.4
Midazolam Hydrochloride	32	9.4	9.4
0Xygen	55	8.9	8.9
Oxygen	55	8.9	8.9
Dapsone	12	8.9	8.9
Nitroglycerin	59	8.8	8.8
Hydroxyzine	51	8.5	8.5
Efavirenz	12	8.5	8.5
Acetylcysteine	10	8.4	8.4
Vincristine Sulfate	30	8.1	8.1
Abacavir Sulfate	10	8.1	8.1
Mercaptopurine	17	7.7	7.7
Lamivudine	30	7.7	7.7
Norepinephrine Bitartrate	14	7.7	7.7
Ampicillin	8	7.6	7.6
Ampicillin Sodium	8	7.6	7.6
Norepinephrine	10	7.4	7.4
Rocuronium Bromide	11	7.4	7.4
Lamivudine Oral	23	7.2	7.2
Esomeprazole	55	7.1	7.1
Zidovudine	12	7.1	7.1
Derma Foam Excel Hand Sanitizer	7	6.9	6.9
Ethanol	7	6.9	6.9
Alteplase	13	6.8	6.8
Magnesium Sulfate In Water For	11	6.8	6.8
Pyrazinamide	8	6.7	6.7
Metronidazole Topical	40	6.7	6.7
Magnesium Sulfate Heptahydrate	11	6.6	6.7
Atropine	7	6.6	6.6
Magnesium Sulfate	11	6.6	6.6
Dextrose	11	6.6	6.6
Dextrose Monohydrate	11	6.5	6.5
Quetiapine Fumarate	24	6.4	6.4
Diphenhydramine Hcl	9	6.4	6.4
Isoniazid	13	6.3	6.3
Carbamazepine	53	6.3	6.3
Fentanyl Citrate	14	6.2	6.2
Brentuximab Vedotin	8	6.1	6.1
Itraconazole	9	6.1	6.1
Amikacin	13	6.0	6.0
Phenobarbital	11	6.0	6.0
Atropine Sulfate	8	5.8	5.8
Posaconazole Delayed-Release	8	5.7	5.7
Adrenalinum	30	5.7	5.7
Valproate Sodium	15	5.7	5.7
Tizanidine Hydrochloride	13	5.7	5.7
Valproic Acid	22	5.5	5.5
Ifosfamide	15	5.5	5.5
Minocycline	8	5.4	5.4
Bupropion Hydrochloride	65	5.3	5.3
Lamotirigine	46	5.1	5.1
Lamotrigine Extended-Release	46	5.1	5.1
Lamotrigine Chewable Dispersible	46	5.1	5.1
Bendamustine Hcl	10	5.1	5.1
Fentanyl	61	5.0	5.0
Thiotepa	6	4.9	4.9
Metoclopramide	34	4.9	4.9
Fondaparinux Sodium	5	4.9	4.9
Posaconazole	10	4.8	4.8
Eszopiclone	15	4.6	4.6
Tenofovir Disoproxil Fumarate Tablets	5	4.5	4.6
Pegaspargase	7	4.5	4.5
Meropenem	18	4.4	4.4
Cefepime	8	4.4	4.4
Nevirapine	5	4.4	4.4
Irinotecan Hydrochloride	7	4.3	4.3
Imatinib	9	4.0	4.0
Guanfacine	4	4.0	4.0
Etoposide	35	3.8	3.8
Lacosamide	17	3.6	3.6
Risperidone	56	3.4	3.4
Deferasirox	11	3.3	3.3
Carboplatin	51	3.2	3.2
Methadone Hydrochloride	4	2.9	2.9
Amphetamine	3	2.8	2.8
Docetaxel Anhydrous	24	2.8	2.8
Docetaxel	24	2.8	2.8
Gemcitabine Hydrochloride	18	2.7	2.7
Temozolomide	7	2.6	2.6
Gefitinib	3	2.6	2.6
Botulinum Toxin Type A	4	2.5	2.5
Axicabtagene Ciloleucel	3	2.4	2.4
Remdesivir	4	2.4	2.4
Teriflunomide	13	2.3	2.3
Onabotulinumtoxina	19	1.9	1.9
Hydrocodone Bitartrate	8	1.4	1.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.